ClosedSuppliesEuropeanOpen

DTaP-IPV-Hib-HepB Vaccines 2021

IUC-RIVM · Open · 1 lots · 241029
Type
Supplies
33651600
Estimated value
Not published
To deadline
Ongoing
Knock-outs
n/a
exclusion grounds
Award basis
Best price-quality ratio
Assess manuallyconfidence low

The National Institute for Public Health and the Environment (RIVM) is seeking suppliers for the supply of DTaP-IPV-Hib-HepB vaccines for the Dutch Immunization Programme, including the Dutch Caribbean. The procurement is an open procedure aimed at securing a continuous and reliable supply of high-quality vaccines that comply with EU and national regulations. Suppliers must demonstrate that they can supply the full product line, including the correct dosages, packaging, and storage conditions. The contract duration spans multiple years with regular deliveries, whereby RIVM requires strict quality control, traceability, and timely delivery. The tender offers an opportunity for companies with experience in vaccine production, distribution, and logistics within the healthcare sector.

Supplies · Open · European procedure

European
Contracting authority
Contract type
Supplies
Open
Estimated value
Estimate not published
Submission deadline
Ongoing
Scope
European
European procedure
Lots
1
1 lots
Main CPV code
Location
Bilthoven
CharacteristicsCPV 33SuppliesEU tenderDTaPIPVHib

01What is being requested

The National Institute for Public Health and the Environment (RIVM) is seeking suppliers for the supply of DTaP-IPV-Hib-HepB vaccines for the Dutch Immunization Programme, including the Dutch Caribbean. The procurement is an open procedure aimed at securing a continuous and reliable supply of high-quality vaccines that comply with EU and national regulations. Suppliers must demonstrate that they can supply the full product line, including the correct dosages, packaging, and storage conditions. The contract duration spans multiple years with regular deliveries, whereby RIVM requires strict quality control, traceability, and timely delivery. The tender offers an opportunity for companies with experience in vaccine production, distribution, and logistics within the healthcare sector.

The objective of this ITT is to fulfil the need for DTaP-IPV-Hib-HepB vaccine for the Dutch Immunization Programme (including the Dutch Caribbean).

33651600Supplies
1Lot 1€1

02Exclusion grounds

Exclusion grounds — consult the ESPD
  • No specific exclusion grounds were extracted. In a European tender, the mandatory and discretionary grounds of art. 2.86/2.87 of the Dutch Procurement Act almost always apply — check the European Single Procurement Document (ESPD).

03Value in context

Estimate not published

The contracting authority did not publish an estimated value — common for a large share of contracts. The EU threshold for leveringen is € 221.000, for reference.

04Likely competitors

#Likely bidderFitWins
1GlaxoSmithKline B.V.SME78
2Johnson & Johnson Medical B.V.SME7716×
3Mediost B.V.SME7714×
4Fuego Tiel B.V.SME74
5Genzyme Europe B.VSME71
6Vandeputte MedicalUnknown71

05Legal themes that may be relevant here

06Frequently asked questions

What is the objective of this tender?
The objective of this contract is to fulfil the need for DTaP-IPV-Hib-HepB vaccines for the Dutch Immunization Programme, including the Dutch Caribbean.
For which regions is the supply of the vaccines intended?
The supply of the DTaP-IPV-Hib-HepB vaccines is intended for the Dutch Immunization Programme, whereby the supply also includes the Dutch Caribbean.

Automatically compiled from the official tender data and documents.

07Estimated value versus the market

p25
€ 317K
median
€ 892K
p75
€ 3,3 mln
deze opdracht

Gegunde waarden in CPV 33 · leveringen n=528